1. Home
  2. JF vs KTTA Comparison

JF vs KTTA Comparison

Compare JF & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

JF

J and Friends Holdings Limited American Depositary Shares

SELL

Current Price

$0.90

Market Cap

17.4M

Sector

N/A

ML Signal

SELL

Logo Pasithea Therapeutics Corp.

KTTA

Pasithea Therapeutics Corp.

SELL

Current Price

$0.48

Market Cap

15.6M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
JF
KTTA
Founded
2012
2020
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.4M
15.6M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
JF
KTTA
Price
$0.90
$0.48
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
5.6K
★ 1.4M
Earning Date
12-01-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 77.07
EPS
★ N/A
N/A
Revenue
N/A
★ $486,559.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 3130.37
52 Week Low
$0.81
$0.32
52 Week High
$1.19
$2.06

Technical Indicators

Market Signals
Indicator
JF
KTTA
Relative Strength Index (RSI) 45.09 49.53
Support Level $0.81 $0.42
Resistance Level $1.03 $0.57
Average True Range (ATR) 0.04 0.08
MACD -0.00 -0.00
Stochastic Oscillator 0.13 48.59

Price Performance

Historical Comparison
JF
KTTA

About JF J and Friends Holdings Limited American Depositary Shares

J and Friends Holdings Ltd providing merchant digitalization and commerce-enablement solutions to small and medium enterprises (SME). Its solutions feature critical functionality that SMEs need to engage with consumers, manage their operations, accept payments, and grow their business. Such solutions empower single- and multi-location retailers, restaurants, and other SMEs to compete successfully in an omni-channel market environment by engaging with consumers across online, mobile, and physical channels. The group conducts all of its current operations in Australia and generates revenues from continuing operations are derived from within Australia.

About KTTA Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. The disorders covered includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module). The Company has reportable segment, which is the business of research and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers.

Share on Social Networks: